Titlebook: Chemotherapy; Volume 8 Cancer Chem K. Hellmann,T. A. Connors Book 1976 Plenum Press, New York 1976 cancer.chemotherapy.kinetics.pharmacokin

只看該作者 · 發(fā)表于 2025-3-28 17:15:48

Pharmacokinetics of Futraful (FT-207) for Clinical Application,lear that FT-207 is a masked or transport form. Therefore although FT-207 itself shows a very week direct activity against tumor cells, after entering the body, FT-207 is activated to 5-FU and thus becomes a potent carcinostatic substance.

只看該作者 · 發(fā)表于 2025-3-28 20:19:43

只看該作者 · 發(fā)表于 2025-3-29 01:54:37

只看該作者 · 發(fā)表于 2025-3-29 04:18:03

只看該作者 · 發(fā)表于 2025-3-29 07:23:44

只看該作者 · 發(fā)表于 2025-3-29 13:28:17

只看該作者 · 發(fā)表于 2025-3-29 16:51:54

只看該作者 · 發(fā)表于 2025-3-29 23:25:10

只看該作者 · 發(fā)表于 2025-3-30 03:07:14

只看該作者 · 發(fā)表于 2025-3-30 04:04:52

Differential Immunosuppressive Effects of Anticancer Agents on Lymphoid Subpopulations,treatment also caused marked suppression of antibody production to SRBC or LPS, whereas treatment uith Azathioprine, Hydrocortisone, Mitomycin C or FT-207 caused only moderate suppression of LPS-PFC. Treatment uith Cyclophosphamide or Azathioprine increased the blastogenic response to PHA. Whereas t

		自動登錄	找回密碼
密碼			To register

關于派博傳思			派博傳思旗下網(wǎng)站			友情鏈接
派博傳思介紹	公司地理位置	論文服務流程	影響因子官網(wǎng)	吾愛論文網(wǎng)	大講堂	北京大學	Oxford Uni.	Harvard Uni.
發(fā)展歷史沿革	期刊點評	投稿經(jīng)驗總結(jié)	SCIENCEGARD	IMPACTFACTOR	派博系數(shù)	清華大學	Yale Uni.	Stanford Uni.
\|Archiver\|手機版\|小黑屋\| 派博傳思國際 ( 京公網(wǎng)安備110108008328) GMT+8, 2026-1-30 09:23
Copyright © 2001-2015 派博傳思京公網(wǎng)安備110108008328 版權(quán)所有 All rights reserved